Home2024December22FDA approves weight-loss drug Zepbound to treat sleep apnea – The Washington Post FDA approves weight-loss drug Zepbound to treat sleep apnea – The Washington Post December 22, 2024betadmin It marks the first medication for certain patients with the condition. #stockmarket #breaking
Inside Elon Musk’s Shock-and-Awe Months in the White House – WSJ $TSLA #Tesla None #stockmarket #breaking
Nasdaq futures rise after Wall Street rebound; Kospi soars 13%, triggers trading curbs: Live updates – CNBC $NVDA #Nasdaq The after-hours moves followed a powerful rally during Thursday’s regular session, led by Microsoft. #stockmarket #breaking
Bank of America CEO says the market “will punish people if we don’t have an independent Fed” – CBS News Bank of America Chairman and CEO Brian Moynihan stated last week that, as President Trump seeks a new chair of…